PURE — Pure Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapSucker Stock

Annual balance sheet for Pure Biosciences, fiscal year end - July 31st, USD millions except per share, conversion factor applied.

	2020 July 31st	2021 July 31st	2022 July 31st	2023 July 31st	2024 July 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3.84	2.39	3.39	1.09	0.349
Net Total Accounts Receivable
Net Total Receivables	1.09	0.368	0.201	0.285	0.298
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	5.57	3.2	3.86	1.6	0.805
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.316	0.74	0.62	0.221	0.013
Net Intangible Assets
Total Assets	6.32	4.3	4.48	1.82	0.818
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	1.51	0.97	0.575	0.532	0.733
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.51	0.97	0.575	1.55	3.68
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	4.81	3.33	3.91	0.272	-2.86
Total Liabilities & Shareholders' Equity	6.32	4.3	4.48	1.82	0.818
Total Common Shares Outstanding